Clinical Trial Update: The EFFect of hIgh Dose ClopIdogrel treatmENT in Patients With Clopidogrel Resistance [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating high-dose clopidogrel for clopidogrel resistance in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Bursa Postgraduate Hospital | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED